What is the recommended management of spontaneous bacterial peritonitis, including initial antibiotic therapy, albumin administration, and secondary prophylaxis?

Management of Spontaneous Bacterial Peritonitis

For spontaneous bacterial peritonitis, immediately start IV third-generation cephalosporin (cefotaxime 2g every 8 hours) plus IV albumin (1.5 g/kg on day 1, then 1 g/kg on day 3), and initiate secondary prophylaxis with oral ciprofloxacin 500 mg daily after resolution. 1

Initial Antibiotic Therapy

Community-Acquired SBP

• Start IV third-generation cephalosporin as first-line therapy (cefotaxime 2g IV every 8 hours for 5-7 days) 1, 2
• Begin antibiotics empirically when ascitic fluid PMN count >250/mm³, before culture results return 1

Healthcare-Associated or Nosocomial SBP

• Use broad-spectrum antibiotics as first-line if the patient has:
  • Healthcare-associated or nosocomial infection
  • Recent exposure to broad-spectrum antibiotics
  • Sepsis or septic shock at presentation 1

Monitoring Response

• Perform repeat paracentesis at 48 hours to assess treatment response 1
• Treatment failure is defined as <25% decrease in PMN count from baseline 1
• If treatment fails: broaden antibiotic coverage and obtain abdominal imaging to rule out secondary bacterial peritonitis 1
• Continue antibiotics for 5-7 days total 1

Albumin Administration

Albumin reduces both renal impairment and mortality—this is critical for outcomes. 1, 3

Dosing Protocol

• 1.5 g/kg IV at diagnosis (day 1)
• 1.0 g/kg IV on day 3 1, 3

Who Benefits Most

Albumin is particularly beneficial in patients with:

• Acute kidney injury (any stage)
• Serum creatinine >1.0 mg/dL
• Blood urea nitrogen >30 mg/dL
• Total bilirubin >5 mg/dL 1

The landmark trial by Sort et al. demonstrated that albumin reduced renal impairment from 33% to 10% and in-hospital mortality from 29% to 10% 3. Recent real-world data confirms that guideline-recommended albumin administration is associated with reduced in-hospital mortality and lower rates of severe AKI 4, 5. Albumin is not just volume expansion—it has anti-inflammatory and immunomodulatory effects that are essential in preventing hepatorenal syndrome.

Secondary Prophylaxis (Prevention of Recurrence)

All patients who survive an episode of SBP require lifelong secondary prophylaxis until ascites resolves or liver transplantation occurs 1.

Antibiotic Options

• Oral ciprofloxacin 500 mg daily (preferred in the US since norfloxacin was withdrawn) 1
• Rifaximin showed lower 6-month SBP recurrence (4% vs 14% with norfloxacin) in limited data 1, 6
• Trimethoprim-sulfamethoxazole is used by some experts but lacks robust evidence 1

Important Caveat on Resistance

Be aware that fluoroquinolone prophylaxis is associated with significant antibiotic resistance. In Veterans Health Administration data, patients on ciprofloxacin prophylaxis who developed SBP had 34% fluoroquinolone resistance versus 14% in those without prophylaxis 7. This means if breakthrough SBP occurs on prophylaxis, you must use broad-spectrum antibiotics empirically, not fluoroquinolones.

Without prophylaxis, the 1-year SBP recurrence rate is 68%, reduced to 20% with norfloxacin 1. The mortality benefit of preventing recurrent SBP outweighs resistance concerns, but resistance patterns must guide empiric therapy for breakthrough infections.

Additional Management Considerations

Non-Selective Beta Blockers

• Temporarily hold NSBBs if the patient develops:
  • Hypotension (mean arterial pressure <65 mm Hg)
  • Acute kidney injury 1

Bacterascites (PMN <250/mm³ with positive culture)

• Do not treat with antibiotics if asymptomatic—most cases self-resolve 1
• Perform repeat paracentesis to monitor for progression to SBP 1

Bundle Adherence Improves Outcomes

Recent national cohort data shows that receiving more components of the SBP care bundle (antibiotics within 48 hours, IV albumin, repeat paracentesis, recognition of SBP, discharge prophylaxis) progressively reduces mortality: patients receiving 5 bundle components had 56% lower mortality compared to those receiving ≤2 components 4. This emphasizes the importance of systematic, protocol-driven care.

Healthcare Disparities

Be aware that Black patients are less likely to receive guideline-recommended albumin (OR 0.76) 5. Gastroenterology/hepatology consultation increases appropriate albumin use (OR 1.60) 5. Ensure equitable access to evidence-based care through protocols and consultation.